Phase I, single ascending-dose trial of the tolerability and pharmacokinetics of setrobuvir in healthy volunteers

Trial Profile

Phase I, single ascending-dose trial of the tolerability and pharmacokinetics of setrobuvir in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Nov 2014

At a glance

  • Drugs Setrobuvir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Anadys Pharmaceuticals
  • Most Recent Events

    • 31 Oct 2008 Results presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases.
    • 24 Sep 2008 Status changed from recruiting to completed as reported in an Anandys media release.
    • 12 Jun 2008 Status changed from planning to recruiting according to Anadys media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top